| Primary |
| Type 2 Diabetes Mellitus |
61.7% |
| Diabetes Mellitus |
10.9% |
| Type 1 Diabetes Mellitus |
10.9% |
| Device Therapy |
4.8% |
| Product Used For Unknown Indication |
2.0% |
| Type Ii Diabetes Mellitus |
1.8% |
| Hypertension |
1.7% |
| Blood Pressure |
1.3% |
| Cardiac Disorder |
0.7% |
| Pain |
0.7% |
| Rash |
0.7% |
| Cardiac Failure Congestive |
0.6% |
| Depression |
0.6% |
| Blood Cholesterol |
0.4% |
| Seasonal Allergy |
0.4% |
| Affective Disorder |
0.2% |
| Atrial Fibrillation |
0.2% |
| Blood Cholesterol Abnormal |
0.2% |
| Blood Cholesterol Increased |
0.2% |
| Blood Glucose Decreased |
0.2% |
|
| Device Malfunction |
32.4% |
| Injury Associated With Device |
17.8% |
| Product Quality Issue |
14.2% |
| Malaise |
3.6% |
| Visual Impairment |
3.6% |
| Wrong Drug Administered |
3.2% |
| Hypoglycaemia |
2.8% |
| Visual Acuity Reduced |
2.8% |
| Feeling Abnormal |
2.4% |
| Injection Site Pain |
2.0% |
| Nausea |
2.0% |
| Pain |
2.0% |
| Unevaluable Event |
2.0% |
| Injection Site Haemorrhage |
1.6% |
| Vomiting |
1.6% |
| Weight Decreased |
1.6% |
| Blood Glucose Increased |
1.2% |
| Hyperglycaemia |
1.2% |
| Overdose |
1.2% |
| Tremor |
1.2% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
54.6% |
| Product Used For Unknown Indication |
12.8% |
| Diabetes Mellitus |
10.5% |
| Type 1 Diabetes Mellitus |
6.4% |
| Device Therapy |
5.5% |
| Type Ii Diabetes Mellitus |
2.2% |
| Hypertension |
1.9% |
| Blood Pressure |
1.7% |
| Diabetes |
0.7% |
| Prophylaxis |
0.5% |
| Insulin-requiring Type 2 Diabetes Mellitus |
0.5% |
| Depression |
0.3% |
| Pain |
0.3% |
| Diabetic Neuropathy |
0.3% |
| Type I Diabetes Mellitus |
0.3% |
| Asthma |
0.3% |
| Blood Glucose |
0.3% |
| Thyroid Disorder |
0.3% |
| Blood Glucose Increased |
0.3% |
| Hyperlipidaemia |
0.2% |
|
| Device Malfunction |
52.2% |
| Product Quality Issue |
16.0% |
| Blood Glucose Increased |
4.4% |
| Visual Impairment |
4.0% |
| Visual Acuity Reduced |
2.7% |
| Wrong Drug Administered |
2.4% |
| Weight Decreased |
2.1% |
| Hypoglycaemia |
2.1% |
| Malaise |
1.4% |
| Weight Increased |
1.3% |
| Hyperglycaemia |
1.2% |
| Hospitalisation |
1.2% |
| Injection Site Pain |
1.2% |
| Tremor |
1.2% |
| Death |
1.2% |
| Vision Blurred |
1.2% |
| Cerebrovascular Accident |
1.1% |
| Myocardial Infarction |
1.1% |
| Pneumonia |
1.0% |
| Injection Site Haemorrhage |
1.0% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
59.7% |
| Diabetes Mellitus |
17.3% |
| Device Therapy |
6.7% |
| Type 1 Diabetes Mellitus |
4.5% |
| Product Used For Unknown Indication |
3.2% |
| Hypertension |
2.4% |
| Cardiac Disorder |
1.2% |
| Anticoagulant Therapy |
0.8% |
| Blood Cholesterol |
0.8% |
| Blood Pressure |
0.5% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Pain |
0.4% |
| Renal Disorder |
0.4% |
| Sleep Disorder |
0.4% |
| Atrial Fibrillation |
0.3% |
| Diabetes |
0.3% |
| Osteoporosis |
0.3% |
| Thyroid Disorder |
0.3% |
| Affective Disorder |
0.2% |
| Arrhythmia |
0.2% |
|
| Visual Acuity Reduced |
17.2% |
| Visual Impairment |
12.0% |
| Weight Decreased |
6.8% |
| Death |
6.4% |
| Myocardial Infarction |
6.4% |
| Weight Increased |
6.4% |
| Cerebrovascular Accident |
5.2% |
| Malaise |
4.4% |
| Cardiac Disorder |
4.0% |
| Neoplasm Malignant |
3.6% |
| Blood Glucose Increased |
3.2% |
| Adverse Event |
2.8% |
| Pancreatic Carcinoma |
2.8% |
| Pneumonia |
2.8% |
| Renal Disorder |
2.8% |
| Renal Failure |
2.8% |
| Tremor |
2.8% |
| Vision Blurred |
2.8% |
| Arthropathy |
2.4% |
| Incorrect Product Storage |
2.4% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
80.0% |
| Hypertension |
20.0% |
|
|
